#IOVA
-

Iovance Stock Jumps 24% After $55 Million Revenue Guidance Raise
Iovance Biotherapeutics surged after lifting its 2026 revenue outlook by $55 million, driven by accelerating demand for Amtagvi in advanced…

Iovance Biotherapeutics surged after lifting its 2026 revenue outlook by $55 million, driven by accelerating demand for Amtagvi in advanced…